期刊文献+

Bcl-2基因反义核酸增强三氧化二砷对NB4细胞凋亡效应 被引量:2

The antisense phosphorothioate oligodeoxynucleotides of bcl-2 oncogene enhances the apoptotic effect of As_2O_3 on NB4 leukemic cells
下载PDF
导出
摘要 目的 :研究和探索bcl- 2基因反义核酸 (bcl- 2ASODN)是否能提高三氧化二砷 (As2 O3 )对NB4白血病细胞的凋亡效应。方法 :采用微量细胞培养的方法 ,观察反义核酸、砷剂单独以及反义核酸、砷剂联合培养NB4细胞的生物效应和凋亡形态变化 ;用免疫组化的方法 ,结合流式细胞技术 ,测定NB4细胞的DNA和Bcl- 2蛋白的变化。结果 :As2 O3 (0 2 5 μmol/L) +bcl - 2ASODN(10 0 μmol/L)联合诱导NB4细胞凋亡作用显著强于单用As2 O3 (0 2 5μmol/L)或 bcl- 2ASODN(10 0 μmol/L) (P <0 0 1)。流式细胞仪检测显示 ,联合用药Bcl- 2蛋白表达亦明显少于反义核酸、砷剂单独给药组 (P <0 0 1)。结论 :bcl- 2基因反义核酸能明显提高和显著增强As2 O3 对NB4白血病细胞的致凋亡效应。 AIM: To study and explore whether the antisense phosphorothioate oligodeoxynucleotides (ASODN) of bcl-2 oncogene would increase the apoptotic effect of As 2O 3 on NB4 leukemic cells. METHODS: The biological and morphological changes in NB4 cells from microculture with As 2O 3, bcl-2 ASODN or both were observed. The changes in DNA content and Bcl-2 protein of NB4 cells from microculture with As 2O 3, bcl-2 ASODN or both were determined by tissue chemistry and flowcytometry. RESULTS: There was much more apoptotic effect of As 2O 3 on NB4 cells while it combined with bcl-2 ASODN (ASODN 10 0 μmol/L+ As 2O 3 0 25 μmol/L) than alone(ASODN 10 0 μmol/L or As 2O 3 0 25μmol/L),and so did inhibitory effect of Bcl-2 protein expression by flow cytometry. CONCLUSION: The bcl-2 ASODN can enhance the apoptotic effect of As 2O 3 on NB4 leukemic cells. [
作者 沈伟利 张洹
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2001年第7期618-621,共4页 Chinese Journal of Pathophysiology
基金 广东省自然科学基金资助项目 (No .980 710 ) 国家自然科学基金资助项目 (No .39870 36 1)
关键词 BCL-2基因 反义核酸 三氧化二砷 NB4细胞 细胞凋亡 基因表达 白血病 Oligonucleotides, antisense Genes, bcl-2 Apoptosis
  • 相关文献

参考文献4

二级参考文献11

  • 1孙鸿德,中国中西医结合杂志,1992年,12卷,170页
  • 2陆道培,白血病治疗学,1992年
  • 3孙关林,中华血液学杂志,1990年,11卷,402页
  • 4孙洪德,中国中西医结合杂志,1992年,12卷,170页
  • 5孙关林,中华血液学杂志,1992年,3卷,135页
  • 6张之南,血液病诊断及疗效标准,1991年
  • 7团体著者,药材学,1960年
  • 8Fionna J K,Leukemia,1995年,9卷,131页
  • 9Minh L,Proc Natl Acad Sci USA,1994年,91卷,6569页
  • 10Hockenbery D M,Cell,1993年,75卷,241页

共引文献606

同被引文献17

  • 1郭伟剑.恶性肿瘤的电化学疗法[J].国外医学(肿瘤学分册),1996,23(6):349-351. 被引量:18
  • 2Cummings J,Anderson L,Willmott N,et al.The molecular pharmacology of doxorubicin in vivo[J].Eur J Cancer,1991,27(3):532-535.
  • 3Caroline R,Carlos F,Patrick M,et al.Role of the Raf signal transduetion cascade in the in vitro resistance to the anticancer drug doxorubicin[J].Clin Caner Res,2001,46(7):2898-2907.
  • 4Kim SH,Lee SH,Kwak NH,et al.Effects of the activated Raf protein kinase on the human muhidrug resistance 1(MDR1)gene promoter[J].Cancer Lett,1996,98(6):199-205.
  • 5Cornwell MM,Smith DE.A signal transduction pathway for activation of the mdr1 promoter involves the proto-oncogene c-raf kinase[J].J Biol Chem,1993,268(7):15347-15350.
  • 6Mas VM,Hernandez H,Plo I,et al.Protein kinase Cζmediated Raf-1/extracellular-regulated kinase activation by daunorubicin[J].Blood,2003,101(8):1543-1550.
  • 7Hanahan D,Weinberg RA.The hallmarks of cancer[J].Cell,2000,100(5):57-70.
  • 8Vogelatein B,Kinzler KW.Cancer genes and the pathways they control[J].Nat Med,2004,10(9):789-799.
  • 9Kornblau SM,Womble M,Qiu YH,et al.Simultaneous activation of multiple signal transduction pathways confers poor prognosis in acute myelogenous leukemia[J].Blood,2006,108(7):2358-2365.
  • 10Wilhelm S,Carter C,Lynch M,et al.Discovery and development of sorafenib:a multikinase inhibitor for treating cancer[J].Nat Rev Drug Discov,2006,57(5):835-844.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部